Visualitza VHIO - Articles científics per autor "Tabernero Caturla, Josep"
Ara mostrant els elements 1-20 d 72
-
A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy
Mancuso, Francesco Mattia; Ros Montañá, Fco. Javier; Argilés Martinez, Guillem; Martini, Giulia; Sanz Garcia, Enrique; Baraibar Argota, Iosune; Salva Ballabrera, Francesc; Noguerido Castro, Alba; Cuadra-Urteaga, Jose Luis; Fasani, Roberta; Garcia Rodriguez, Ariadna; Jiménez Catalan, Juan José; Aguilar, Susana; Hernandez Losa, Javier; Braña Garcia, Irene; Nuciforo, Paolo Giovanni; Tabernero Caturla, Josep; Salazar, Ramón; Vivancos Prellezo, Ana; Landolfi, Stefania; Comas Navarro, Raquel; Ruiz Pace, Fiorella; Dienstmann, Rodrigo; Elez, Elena; Mulet Margalef, Nuria; Sanso, Miriam (MDPI, 2022-12-21) -
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients
Toledano, Marta; Gómez España, Maria Auxiliadora; Elez Fernandez, Mª Elena; Grávalos, Cristina; García-Alfonso, P.; Rodríguez, R.; Tabernero Caturla, Josep (Elsevier, 2023-03) -
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology
Lazar, Vladimir; Zhang, Baolin; Magidi, Shai; Raymond, Eric; Ducreux, M.; Felip Font, Enriqueta; Tabernero Caturla, Josep; Le Tourneau, Christophe (SAGE Publications, 2023) -
Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer
Ros Montañá, Fco. Javier; Balconi, Francesca; Baraibar Argota, Iosune; Salva Ballabrera, Francesc; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena; Saoudi Gonzalez, Nadia (Frontiers Media, 2023-02-02) -
Advances in the systemic treatment of therapeutic approaches in biliary tract cancer
Mirallas Viñas, Oriol; López-Valbuena, D.; García Illescas, David; Verdaguer Mata, Helena; Tabernero Caturla, Josep; Macarulla Mercadé, Teresa; Fabregat Franco, Carles (Elsevier, 2022-06) -
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights
Elez Fernandez, Mª Elena; Argilés Martinez, Guillem; Matos Garcia, Ignacio; Sanz Garcia, Enrique; Macarulla Mercadé, Teresa; Alsina Maqueda, Maria; Sauri Nadal, Tamara; Verdaguer Mata, Helena; Viaplana Donato, Cristina; García Palmer, Héctor; Nuciforo, Paolo Giovanni; Rodon Ahnert, Jordi; Vivancos Prellezo, Ana; Tabernero Caturla, Josep; Capdevila Castillon, Jaume; Landolfi, Stefania; Ruiz Pace, Fiorella; Ortiz Velez, Carolina; Dienstmann, Rodrigo (Wiley, 2017-06-15) -
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors
Isakoff, S. J.; Tabernero Caturla, Josep; Molife, L. R.; Soria, J.-C.; Vogelzang, N. J.; Argilés Martinez, Guillem; Cervantes, Andrés (Elsevier, 2020-05) -
Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial
Chibaudel, Benoist; Henriques, Julie; Rakez, Manel; Brenner, Baruch; Kim, Tae Won; Martínez-Villacampa, Mercedes; Tabernero Caturla, Josep (American Medical Association, 2020-10-19) -
Back-to-back discovery, co-precision, and prevention
Casadei, Barbara; Tabernero Caturla, Josep (Oxford University Press, 2020-04) -
Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology
Castelo-Branco, L.; Awada, Ahmad; Pentheroudakis, G.; Perez-Gracia, J. L.; Mateo Valderrama, Joaquim; Tabernero Caturla, Josep; Curigliano, Giuseppe (Elsevier, 2021-10) -
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
Gyawali, B.; Dafni, U.; Amaral, T.; Barriuso, J.; Bogaerts, J.; Tabernero Caturla, Josep; de Vries, Elisabeth (BMJ, 2021-06) -
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study
Yoshino, T.; Portnoy, D. C.; Obermannova, Radka; Bodoky, György; Prausová, J.; Tabernero Caturla, Josep; Garcia-Carbonero, Rocio (Oxford University Press, 2019-01-01) -
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
Ros Montañá, Fco. Javier; Baraibar Argota, Iosune; Sardo, Emilia; Mulet Margalef, Núria; Salva Ballabrera, Francesc; Argilés Martinez, Guillem; Martini, Giulia; Ciardiello, Davide; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena (SAGE Publications, 2021-01) -
Cancer Core Europe: A translational research infrastructure for a European mission on cancer
Eggermont, Alexander M M; Apolone, Giovanni; Caldas, Carlos; Lorenzo, Francesco de; Tabernero Caturla, Josep; Celis, Julio E; Baumann, Michael (Wiley Open Access, 2019-01-18) -
Chemorefractory Gastric Cancer: The Evolving Terrain of Third-Line Therapy and Beyond
Alsina Maqueda, Maria; Diez Garcia, Marc; Tabernero Caturla, Josep (MDPI, 2022-03-10) -
Clinical development of therapies targeting TGFβ: current knowledge and future perspectives
Ciardiello, Davide; Elez Fernandez, Mª Elena; Tabernero Caturla, Josep; Seoane Suarez, Joan (Elsevier, 2020-10) -
Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer
Baraibar Argota, Iosune; Mirallas Viñas, Oriol; Ros Montañá, Fco. Javier; Salva Ballabrera, Francesc; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena; Saoudi Gonzalez, Nadia (MDPI, 2021-12) -
Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers
Elez Fernandez, Mª Elena; Macarulla Mercadé, Teresa; Tabernero Caturla, Josep; Saoudi Gonzalez, Nadia; Castet, Florian (Frontiers Media, 2022-10-10) -
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival
Lazar, Vladimir; Magidi, Shai; Girard, Nicolas; Savignoni, Alexia; Martini, Jean-François; Massimini, Giorgio; Braña Garcia, Irene; Tabernero Caturla, Josep; Felip Font, Enriqueta (Nature Research, 2021-04-28) -
Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure–response analysis
Fudio, Salvador; Tabernero Caturla, Josep; Chawla, Sant P.; Longo-Muñoz, Federico; Subbiah, Vivek; Moreno, Victor (Springer, 2021-01)